A detailed history of Engineers Gate Manager LP transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 20,501 shares of ABEO stock, worth $132,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,501
Holding current value
$132,436
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$4.76 - $6.02 $97,584 - $123,416
20,501 New
20,501 $97,000
Q1 2024

May 15, 2024

BUY
$4.07 - $8.68 $72,283 - $154,156
17,760 New
17,760 $128,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $38.4M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.